Breadth and Depth in ADHD: Insights from In Vivo and Ex Vivo Studies
Philip Shaw, PhD, MRCP, MRCPsych
Attention deficit hyperactivity disorder (ADHD) has long been the most common neurodevelopmental disorder with US diagnostic rates rising from 5% to 12% in the last 20 years. Most children with ADHD retain symptoms into adulthood and over 60% have psychiatric or neurodevelopmental co-morbidities. A variety of therapies are widely applied but genuine remediation remains an incompletely solved problem. The brain bases of ADHD and its treatment have been the target of intense investigation for over 40 years employing all varieties of neuroimaging, including MRS. Come hear what we have learned from all that!
Our speaker, Dr. Philip Shaw, with his high-N, high-rigor fMRI, DTI, and now MRS studies ranks among the foremost ADHD neuroimagers in the World. A member of the working group for ADHD treatment guidelines and Lead of the Psychiatric Genomic Consortium for ADHD, he is a highly prized, charming keynote speaker and editorialist for ADHD congresses and journals globally-- and an ideal choice for updating us on ADHD.
